Stockreport

Frost & Sullivan Publishes Q3-2018 Update On Cellect Biotechnology Ltd.

Cellect Biotechnology Ltd. - American Depositary Shares  (APOP) 
US:NASDAQ Investor Relations: cellect.co
PDF TEL AVIV, Israel, Dec. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. is developing a technological platform, the "ApoGraft", which functionally selects stem cells [Read more]